<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="brief-report" dtd-version="1.2" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Immunology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Immunology</journal-title><trans-title-group xml:lang="ru"><trans-title>Russian Journal of Immunology</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1028-7221</issn><issn publication-format="electronic">2782-7291</issn><publisher><publisher-name xml:lang="en">Russian Society of Immunology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">17439</article-id><article-id pub-id-type="doi">10.46235/1028-7221-17439-RBC</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>SHORT COMMUNICATIONS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Short Communication</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Relationship between cytokine production and development of hypothyroidism in glomerulonephritis with nephrotic syndrome</article-title><trans-title-group xml:lang="ru"><trans-title>Взаимосвязь между продукцией цитокинов и развитием гипотиреоза при гломерулонефритах с нефротическим синдромом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kudryashov</surname><given-names>S. I.</given-names></name><name xml:lang="ru"><surname>Кудряшов</surname><given-names>С. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>к.м.н., доцент кафедры поликлинической терапии<italic> </italic></p></bio><bio xml:lang="en"><p>PhD (Medicine), Associate Professor, Department of Polyclinic Therapy</p></bio><email>luizak58@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Karzakova</surname><given-names>L. M.</given-names></name><name xml:lang="ru"><surname>Карзакова</surname><given-names>Л. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>д.м.н., профессор кафедры поликлинической терапии<italic> </italic></p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Department of Polyclinic Therapy</p></bio><email>luizak58@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Alekseeva</surname><given-names>E. P.</given-names></name><name xml:lang="ru"><surname>Алексеева</surname><given-names>Е. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>к.м.н., врач-терапевт</p></bio><bio xml:lang="en"><p>PhD (Medicine), General Practitioner</p></bio><email>luizak58@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Stenina</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Стенина</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>д.м.н., профессор кафедры иммунологии</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Department of Immunology</p></bio><email>luizak58@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="ru">ФГБОУ ВО «Чувашский государственный университет имени И.Н. Ульянова»</institution></aff><aff><institution xml:lang="en">I. Ulyanov Chuvash State University</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="ru">ООО «Центр Медосмотров»</institution></aff><aff><institution xml:lang="en">Medical Examination Center LLC</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">N. Pirogov Russian National Research Medical University</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Министерства здравоохранения РФ</institution></aff></aff-alternatives><content-language>ru</content-language><pub-date date-type="pub" publication-format="electronic" iso-8601-date="2026-10-31"><day>31</day><month>10</month><year>2026</year></pub-date><pub-date date-type="collection"><year>2026</year></pub-date><volume>29</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>645</fpage><lpage>650</lpage><history><date date-type="received" iso-8601-date="2026-03-28"><day>28</day><month>03</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-06-20"><day>20</day><month>06</month><year>2026</year></date></history><pub-history><event event-type="received"><event-desc>Received:<date date-type="received" iso-8601-date="2026-03-28"><day>28</day><month>03</month><year>2026</year></date></event-desc></event><event event-type="accepted"><event-desc>Accepted:<date date-type="accepted" iso-8601-date="2026-06-20"><day>20</day><month>06</month><year>2026</year></date></event-desc></event><event event-type="pub"><event-desc>Published:<pub-date date-type="pub" publication-format="electronic" iso-8601-date="2026-10-31"><day>31</day><month>10</month><year>2026</year></pub-date></event-desc></event></pub-history><permissions><copyright-statement xml:lang="en">Copyright ©; , Kudryashov S.I., Karzakova L.M., Alekseeva E.P., Stenina M.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; , Кудряшов С.И., Карзакова Л.М., Алексеева Е.П., Стенина М.А.</copyright-statement><copyright-holder xml:lang="en">Kudryashov S.I., Karzakova L.M., Alekseeva E.P., Stenina M.A.</copyright-holder><copyright-holder xml:lang="ru">Кудряшов С.И., Карзакова Л.М., Алексеева Е.П., Стенина М.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://rusimmun.ru/jour/article/view/17439">https://rusimmun.ru/jour/article/view/17439</self-uri><abstract xml:lang="en"><p>Glomerulonephritis (GN) with nephrotic syndrome (NS) is one of the main causes of terminal renal failure, which requires costly hemodialysis therapy. GN with NS is often complicated by hypothyroidism. The mechanisms of this condition are not fully understood. The aim of our study was to investigate the relationship between urinary cytokine levels and development of hypothyroidism in GN with NS. The study included 193 patients with GN with NS being hospitalized for active NS. The study protocol included determination of the cytokines levels, i.e., IL-1β, IL-2, IL-4, IL-8, IL-17A, IL-10, receptor antagonist of interleukin-1β (RAIL- 1β) in the morning urine samples using ELISA assay. The urinary cytokine levels were normalized by creatinine index in the morning urine. The serum venous blood levels of thyroid-stimulating hormone (TSH), free fractions of thyroid hormones – thyroxine (T4 free), triiodothyronine (T3 free), antibodies to thyroid peroxidase (anti-TPO) were determined in the serum of venous blood by ELISA. As based in these data, hypothyroidism was observed in 55.1% of cases of GN with NS being associated with activation of the pro-inflammatory cytokine production in kidneys and development of the non-thyroidal disease syndrome. Thyroid hormones and pro-inflammatory cytokines act as antagonists in GN with NS, blocking the production of each other. TSH has a synergistic effect with pro-inflammatory cytokines in GN with NS.</p></abstract><trans-abstract xml:lang="ru"><p>Гломерулонефриты (ГН) с нефротическим синдромом (НС) являются одной из актуальных проблем медицины в связи с недостаточной изученностью их патогенеза и отсутствием эффективных способов их лечения. Нередко ГН с НС осложняются присоединением гипотиреоза, механизмы развития которого до конца не изучены. Целью исследования явилось изучение связи между уровнями цитокинов в моче и развитием гипотиреоза при ГН с НС. В исследование были включены 193 больных ГН НС, госпитализированных в стационар в связи с активным НС. Протокол исследования включал определение в утренней моче методом иммуноферментного анализа (ИФА) уровней цитокинов – IL-1β, IL-2, IL-4, IL-8, IL-17А, IL-10, рецепторного антагониста интерлейкина-1β (RAIL-1β). Уровни цитокинов в моче нормализовали по показателю содержания креатинина в утренней моче. В сыворотке венозной крови определяли уровни тиреотропного гормона (ТТГ), свободных фракций тиреоидных гормонов – тироксина (Т4 св.), трийодтиронина (Т3 св.), антител к тиреопероксидазе (анти-ТПО) методом ИФА. В соответствии с результатами проведенного исследования, гипотиреоз, встречавшийся при ГН с НС в 55,1% случаев, является результатом активации продукции провоспалительных цитокинов в почках и развития синдрома нетиреоидных заболеваний. Тиреоидные гормоны и провоспалительные цитокины действуют при ГН с НС как антагонисты, блокируя продукцию друг друга. ТТГ оказывает синергичное с провоспалительными цитокинами патогенетическое влияние при ГН с НС.</p></trans-abstract><kwd-group xml:lang="en"><kwd>cytokines</kwd><kwd>interleukins</kwd><kwd>glomerulonephritis</kwd><kwd>nephrotic syndrome</kwd><kwd>hypothyroidism</kwd><kwd>non-thyroidal disease syndrome</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>цитокины</kwd><kwd>интерлейкины</kwd><kwd>гломерулонефриты</kwd><kwd>нефротический синдром</kwd><kwd>гипотиреоз</kwd><kwd>синдром нетиреоидных заболеваний</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Карзакова Л.М, Кудряшов С.И., Шестипалова М.В., Леонтьева Е.В. Определение уровней цитокинов в моче в клинической практике // Клиническая лабораторная диагностика, 2019. Т. 64, № 5. C. 287-293. [Karzakova L.M., Kudryashov S.I., Shestipalova M.V., Leontyeva E.V. Determining of cytokine levels in the urine in clinical practice. Klinicheskaya laboratornaya diagnostika = Russian Clinical Laboratory Diagnostics, 2019, Vol. 64, no. 5, pp. 287-293. (In Russ.)]</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Подзолков А.В., Фадеев В.В. Гипотиреоз, субклинический гипотиреоз, высоконормальный уровень ТТГ // Клиническая и экспериментальная тиреоидология, 2009. Т. 5, № 2. С. 4-16. [Podzolkov A.V., Fadeev V.V. Hypothyroidism, subclinical hypothyroidism, high-normal TSH level. Klinicheskaya i eksperimentalnaya tireoidologiya = Clinical and Experimental Thyroidology, 2009, Vol. 5, no. 2, pp. 4-16. (In Russ.)]</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Chang Y.C., Chang C.H., Yeh Y.C., Chuang L.M., Tu Y.K. Subclinical and overt hypothyroidism is associated with reduced glomerular filtration rate and proteinuria: a large cross-sectional population study. Sci. Rep., 2018, Vol. 8, no. 1, 2031. doi: 10.1038/s41598-018-19693-4.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>de Vries E.M., Fliers E., Boelen A. The molecular basis of the non-thyroidal illness syndrome. J. Endocrinol., 2015, Vol. 225, no 3, pp. 67-81.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Gutch M., Kumar S., Gupta K.K. Prognostic Value of Thyroid Profile in Critical Care Condition. Indian J. Endocrinol. Metab., 2018, Vol. 22, no. 3, pp. 387-391.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int., 2021, Vol. 100, no. 4S, pp. S1-S276.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Lasa M., Contreras-Jurado C. Thyroid Hormones Act as Modulators of Inflammation Through Their Nuclear Receptors. Front. Endocrinol., 2022, Vol. 13, 937099. doi: 10.3389/fendo.2022.937099.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Mullur R., Liu Y.Y., Brent G.A. Thyroid hormone regulation of metabolism. Physiol. Rev., 2014, Vol. 94, no. 2, pp. 355-382.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Nam S.M., Kim J.W., Yoo D.Y., Jung H.Y., Chung J.Y., Kim D.W., Hwang I.K., Yoon Y.S. Hypothyroidism increases cyclooxygenase-2 levels and pro-inflammatory response and decreases cell proliferation and neuroblast differentiation in the hippocampus. Mol. Med. Rep., 2018, Vol. 17, no. 4, pp. 5782-5788.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Thapa Karki S., Khatun N., Chapagain R.H., Shrestha N.J., Agrawal S. Hypothyroidism among Children with Nephrotic Syndrome Admitted to a Tertiary Care Centre. JNMA J. Nepal Med. Assoc., 2024, Vol. 62, no. 270, pp. 110-113.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Tumwesige M., Rujumba J., Piloya T., Aujo J.C. Hypothyroidism among children and adolescents with nephrotic syndrome in Mulago National Referral Hospital, Kampala, Uganda; a cross-sectional study. BMC Pediatr., 2024, Vol. 24, no. 1, 132. doi: 10.1186/s12887-024-04610-8.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Yang C., Lu M., Chen W., He Z., Hou X. Thyrotropin aggravates atherosclerosis by promoting macrophage inflammation in plaques. J. Exp. Med., 2019, Vol. 216, no. 5, pp. 1182-1198.</mixed-citation></ref></ref-list></back></article>
